| Tamar Mary Boyd, PHD, LPC | |
|
2231 Jordan Ave, Juneau, AK 99801-8050 | |
| (907) 209-4459 | |
| Not Available |
| Full Name | Tamar Mary Boyd |
|---|---|
| Gender | Female |
| Speciality | Counselor - Professional |
| Location | 2231 Jordan Ave, Juneau, Alaska |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1104488246 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 101YP2500X | Counselor - Professional | 146478 (Alaska) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Tamar Mary Boyd, PHD, LPC 20136 Cohen Dr, Juneau, AK 99801-8212 Ph: (907) 209-4459 | Tamar Mary Boyd, PHD, LPC 2231 Jordan Ave, Juneau, AK 99801-8050 Ph: (907) 209-4459 |
News Archive
Imperial College London is to invest in a new facility at the Babraham Research Campus in Cambridge to support spin-out and scale-up companies, and maximise the impact of research from universities.
MAXIMUS, a leading provider of government services worldwide, announced today that its Federal Services subsidiary has been awarded a one-year contract by the Centers for Medicare & Medicaid Services (CMS) to continue to serve as an independent review entity for reconsiderations of beneficiary appeals for the Medicare Part D program.
Neurotech Pharmaceuticals, Inc., today announced that it was reported in the Proceedings of the National Academy of Sciences that its product candidate NT-501 slowed progression of vision loss in patients with geographic atrophy (GA) associated with dry age-related macular degeneration (AMD) in a Phase 2 study.
Oncolytics Biotech Inc. today announced that it has met the primary overall statistical endpoint in its U.S. Phase 2 single arm clinical trial in patients with squamous cell carcinoma of the lung using intravenous administration of REOLYSIN in combination with carboplatin and paclitaxel in patients with metastatic stage IIIB, or stage IV, or recurrent SCCLC who are chemotherapy naïve for their metastatic or recurrent cancer (REO 021).
"The time may finally be near for the Chinese government to back away from one of its most famous - and controversial - laws," the so-called "one-child policy," GlobalPost reports.
› Verified 6 days ago
Sanaz Ghorbanpoor, Counselor Medicare: Not Enrolled in Medicare Practice Location: 3406 Glacier Hwy, Juneau, AK 99801 Phone: 907-463-3303 | |
Lila A Searer, Counselor Medicare: Not Enrolled in Medicare Practice Location: 3406 Glacier Hwy, Juneau, AK 99801 Phone: 907-463-3303 Fax: 907-463-6858 | |
Leslye Ann Galey, LPC Counselor Medicare: Medicare Enrolled Practice Location: 3260 Hospital Dr, Juneau, AK 99801 Phone: 907-796-8498 | |
Kayli Backes, Counselor Medicare: Not Enrolled in Medicare Practice Location: 3406 Glacier Hwy, Juneau, AK 99801 Phone: 907-463-3303 Fax: 907-463-6858 | |
Justin Parish, Counselor Medicare: Not Enrolled in Medicare Practice Location: 3406 Glacier Hwy, Juneau, AK 99801 Phone: 907-463-3303 | |
Ms. Donna M Zahina, Counselor Medicare: Not Enrolled in Medicare Practice Location: 5594 Aisek St., Juneau, AK 99801 Phone: 907-780-3048 Fax: 907-780-3053 | |
Dany Reyes, Counselor Medicare: Not Enrolled in Medicare Practice Location: 3406 Glacier Hwy, Juneau, AK 99801 Phone: 907-463-3303 Fax: 907-463-6858 |